Using the CD40 system, in vitro proliferation of hairy cell leukemia (HCL) was examined in 43 patients. In this culture system, cells were stimulated by interleukin-4 (IL-4) and anti-CD40 monoclonal antibodies (MoAbs) that were added in soluble form or were cross-linked via their Fc part using FcyRII-transfected mouse fibroblast cells. Proliferation was induced and confirmed by 3H-thymidine incorporation in 14 cases and by the presence of metaphases in 42 cases. 3H-thymidine incorporation showed a heterogeneous pattern: cross-linking of anti-CD40 gave the highest proliferation in 8 cases; in 11 cases, stimulation with anti-CD40 MoAbs alone, without cross-linking also resulted in proliferation; the addition of IL-4 further enhanced 'H-thymidine incorporation in 5 cases, but suppressed this phenomenon in 5 other cases.
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AIRY CELL LEUKEMIA (HCL) is a chronic B-cell
leukemia with a very low proliferative capacity.'" This makes it difficult to study the effects of (autocrine) cytokines or antiproliferative drugs. Attempts at producing metaphases for cytogenetic analysis have, in the majority of cases, largely been unsuccessf~l."~ Even when clonal abnormalities were detected, in most cases, they were present only in a very small number of whereas the cells needed stimulation by mitogenic B-cell stimulators such as pokeweed mitogen (PWM), lipopolysaccharide (LPS), Epstein-Barr virus (EBV), B-cell stimulating factor (BSF-MP6), cytochalasin B, or 12-0-tetradecanoy1phorbol-13-acetate (TPA), not only in short-term,i0." but also in long-term cultures."
Most proliferative and in vitro colony assays to culture malignant B cells also use polyclonal B cell stimulators such as anti-IgM, PWM, TPA, soluble protein A from Staphylococcus aureus, LPS, or EBV, often in conjunction with phytohemagglutinin (PHA) or supernatants from PHA-stimulated lymphocytes.I2 The results of many of these assays proved to be disappointing; moreover, proliferation found in some of the cultures had to be ascribed to residual T In HCL, weak proliferation that could be ascribed to the hairy cells was found after stimulation with B-cell growth identified by the use of immunofluorescence staining of the cultured cells. However, in such cultures, only low percentages of Ki-67' (?9% if costimulated with anti-IgM) or 'H-H factorl.i3.14 or with tumor necrosis factor a (TNFa)4.6.'3,'5 and
The CD40 system proved t o be very effective in obtaining cytogenetic data. With a success rate of 42 of 43 patients tested, we found clonal abnormalities in 8 cases (19%) and nonclonal abnormalities with involvement of one or two abnormal metaphases in another 7 cases. The chromosomes most frequently involved in the abnormal karyotypes, both structurally and numerically, were chromosomes 5, 7, and 14. By fluorescence-activated cell-sorting analysis of the cultured cells, and by immunophenotypic analysis of metaphase spreads, T-cell growth could be excluded and the HCLlineage confirmed. Stimulation via the CD40 antigen is an excellent tool for growing hairy cell leukemia cells. 0 1994 by The American Society of Hematology.
thymidine-positive cells (labeling index, maximally 4.3%) were observed at the end of the culture period despite a sometimes high 3H-thymidine count6." that indicates a lower proliferation index than was expected from the "-thymidine counts as such.
Recently, a new method of B-cell activation and proliferation has been described using stimulation via the CD40 antigen. The CD40 antigen is present on normal B cells and on all malignant B cells starting at the precursor acute lymphocytic leukemia stage,I6 including the malignant plasma cell." At first, proliferation of normal B cells was seen after stimulation with anti-CD40 monoclonal antibodies (MoAbs) in conjunction with anti-IgM, anti-CD20, or TPA." Subsequently, interleukin-4 (IL-4) showed synergy by increasing, among others, CD40 antigen expression." When the anti-CD40 MoAbs were cross-linked via their Fc part using an FcyRII(CD32)-transfected mouse fibroblast cell line (CD32L cells), clonal expansion of B cells was greatly enhanced.20,2'
As far as malignant B cells are concerned, thus far, the CD40 system has only been used to grow cells from chronic lymphocytic leukemia (CLL)22-25 and follicular non-Hodgkin's lymphoma (NHL).2h High proliferative indices were found only after stimulation with IL-4 and anti-CD40 MoAbs cross-linked via CD32L cells, whereas anti-CD40 alone was not effe~tive.'~.~~ After confirming these results for CLL and NHL, we studied the in vitro proliferation of HCL using stimulation via the CD40 antigen. We were able to show induction of cell proliferation in almost all of our HCL cases as measured by 'H-thymidine incorporation. Moreover, the CD40 system proved very suitable for cytogenetic analysis. = 15) or from the spleen (n = 28) by gentle mechanical disruption, washing, and Ficoll-Isopaque (1.077 g/mL; Pharmacia, Uppsala, Sweden) density gradient centrifugation. In most cases, the cells were cryopreserved in 10% dimethylsulfoxide at this stage until further study. After thawing, residual T cells were removed with help of magnetic beads. Cell suspensions were incubated with saturating amounts of anti-CD2 and anti-CD3 (anti-LeuSb and anti-Leu4, Becton Dickinson, Mountain View, CA) MoAbs followed by incubation with sheep-antimouse-coated beads according to the instructions given by the manufacturer (Dynabeads; Dynal, Oslo, Norway). The resulting suspensions always contained less than 0.5% and usually less than 0.1% of CD3+ T cells. used at a final concentration of 0.5 pg/mL. Cells were cultured for 7 days in a fully humidified 5% COz atmosphere at 37°C. For the last 16 hours, of culture, 'H-thymidine 1 pCi/well was added. Cells were harvested with an automatic microharvester, and counts per minute (cpm) were determined on a liquid scintillation spectometer. As control for background 'H-thymidine incorporation, CD32L cells either alone or in combination with imdiated (30 Gy) HCL cells were used. The counts obtained from the irradiated cultures were always subtracted from the counts obtained from the nonirradiated cultures.
MATERIALS AND METHODS

Patients
Immunophenotyping and cyrochemisrry. Analysis of the cultured cells was performed using fluorescein isothiocyanate (FITC)-conjugated anti-CD3 (anti-Leu4) and anti-CD103 (anti-B-l~-7~) and phycoerythnn-conjugated anti-CD19 (B4; Coulter Immunology, Hialeah, FL). As control for the different isotypes of the MoAbs, IgGland IgG2-labeled controls were used. Cells were analyzed on a FACScan (Becton Dickinson), and 10,OOO to 20,000 events were scored. Cytospin preparations were made for morphologic assessment by May-Grlinwald-Giemsa ( M W ) staining and TRAPo reactivity. Moreover, the cells were stained by two-color fluorescence using polyclonal antisera to human Ig light chains (anti-~-FITc and anti-h-tetramethylrhodamhe-isothiocyanate (TRITC), goat-antihuman Ig, Kallestad, Austin, TX).
Immunophenotyping of metaphase cells was undertaken as de~cribed.~' In short, after colcemid (0.025 mg/mL) incubation for 2 to 3 hours, cells were suspended in a hypotonic solution consisting of 50 mmoVL glycerol, 5 mmoVL KCI, 10 mmoVL NaCI, 0.8 mmoV L MgCl,, 1 mmoVL CaC12, and 10 mmoVL sucrose (pH 7.0) for 5 minutes. Cells were transferred to cytocentrifuge chambers and centrifuged for 5 minutes at 1, OOO rpm (Cytospin 2; Shandon, Pittsburgh, PA).'* Slides were stored at 4°C until used. Subsequently, the slides were fixed (40 pL formaldehyde 37% in 50 mL acetone) at room temperature for 1 minute, washed in PBS supplemented by 0.1% bovine serum albumin, and stained with anti-CD3-FITC. a combination of anti-CD19-FITC and anti-CD20-FITC or with anti-light-chain antisera. Nuclear staining was made visible by incubation with propidium iodide. All metaphases found per slide were analyzed to assess the lineage of the cell.
Cyrogenetic analysis. Cells from 6 to l1 l-mL wells were harvested at day 7 of the culture by a pipette. Because of the strong adherence of the hairy cells to the fibroblast layer and the impossibility of separating them, the whole contents of each well were scraped from the bottom, which was rinsed twice with complete culture medium, to which L -4 (50 U/mL) and anti-CD40 (0.25 pg/mL) were added. To obtain good quality chromosomes, a synchronization method was used.'' In brief, fluorodeoxyuridine (5 pmoVL) was added 17 hours before harvest; bromodeoxyuridine (14 mg/mL) was added for a further 5-hour incubation. Two hours before harvesting, colcemid (0.025 rng/mL) was added. Cultures were further processed according to standard techniques. Routine GTG-banding was used.34
Fluorescent in situ hybridization (FISH). Hybridization on metaphase cells's was performed with chromosome-specific library probes namely: pBsl, pBs2, pBs5, pBs7, pBsl4, pBsl7, and pBsl8 (kindly provided by Dr J.W. Gray, Lawrence Livermore National Laboratory, Livermore, CA) labeled by nick translation with fluorescein-16-deoxyuridine triphosphate ( d m ) (Boehringer) or rhodamin-4-aUTP (Amersham, Arlington Heights, IL). The chromosome-specific library probes were preannealed with 50-fold human cot-l DNA (Boehringer, Mannheim, Germany) to suppress nonunique sequences. The slides were separately denatured at 80°C. Hybridization took place at 37°C for 48 hours. Posthybridization, the slides were washed with 50% formamia2 X saline sodium citrate (SSC) 42°C; 0.2 X SSC 60°C; 4 X SSC + 0.05% Tween-20 and phosphate-buffered saline. Subsequently, the slides were embedded in vectashield (Vector Laboratories, Burlingame, CA) antifade medium with 4',6-diamidino-2-phenylindole dihydrochloride counterstain.
RESULTS
In the first few days of culture, small groups of hairy cells were formed adherent to the mouse fibroblast cells, whereas in the absence of CD40, no such aggregates were seen. After 1 week, the majority of hairy cells had developed into large spherical coherent aggregates that were strongly fixed to the fibroblast layer. The irradiated fibroblasts were swollen with very large nuclei that could often be seen in the middle of the spheres (Fig 1, A and B) . M W and TRAP on cytospin preparations of the cultured cells showed that the hairy cells were increased in size with basophilic cytoplasm, whereas the nucleus frequently harbored a nucleolus. However, plasmacytoid differentiation was not seen. The hairy cells showed a strong adherence to the mouse fibroblast cells that could easily be discerned by their large size and giant nuclei (Fig 1, D and E ). In all cases tested (n = 1 l), strong TRAP reactivity was seen (Fig 1C) . Immunophenotyping of the cultured cells by fluorescence-activated cell-sorting (FACS) analysis always disclosed the absence of CD3+ cells and 
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All results are expressed as mean cpm of six replicate cultures. The SD always measured less than 10%. The culture combination with the Background represents the 3H-thymidine incorporation by the stimulated (with aCD40 + IL-4) irradiated CD32L cells alone, or in combination with irradiated hairy cells. The highest counts from either of these control cultures were used as baseline; only counts exceeding this level were considered as true HCL-specific 3H-thymidine incorporation.
best results is underlined.
confirmed the presence of monoclonal B cells by CD19 expression in all cases assessed (n = 19). Strong reactivity with the hairy cell-specific antigen CD103 (B-ly-7) was also found in all cases studied (n = 13). Two-color fluorescence on cytospin preparations with anti-~-HTC and antih-TRITC (and vice versa) disclosed in all cases a lightchain restriction (n = 12); in 6 cases, only expression of the HCL-associated light chain was seen (80% to 95% of all cells), whereas in the other 6 HCL after culture, low percentages (1% to 12%, median 3.5%) cells were seen that expressed the other light chain.
3H-thymidine incorporation was measured in 14 HCL cases, all of which were stimulated by anti-CD40 MoAbs, both with and without IL-4 in the presence or absence of CD32L cells. No uniform pattern was seen (Table 1) : in l 1 cases, stimulation by anti-CD40 alone (without cross-linking) resulted in a median 2.6-fold (1.5-to 10-fold) increase of 3H-thymidine incorporation that was further enhanced (1.3-to %fold) by the addition of L -4 in 5 cases. In another 5 cases, IL-4 showed suppression of the CD40-induced stimulation. Cross-linking of anti-CD40 (using CD32L cells) gave the highest proliferation in 8 cases; in this combination, IL-4 induced a further increase of 3H-thymidine incorporation in 5 cases ( Table 1 ). The addition of CD32L cells alone never resulted in a significant extra stimulation.
Cytogenetic analysis was performed successfully in 42 of 43 cases either at the first attempt or subsequent attempts. A high mitotic index and good morphology of the chromosomes ensured a satisfactory result in 98% of the cases analyzed ( Table 2 ). The median number of metaphases analyzed was 30 (range 6 to 46). In 27 cases, a normal karyotype was obtained. Clonal abnormalities were found in 19% (8 of 42), whereas in another 7 cases, nonclonal abnormalities with one or two abnormal metaphases were seen. When clonal abnormalities were present, they were found to be in the greater majority of metaphases. The chromosomes most frequently involved in the abnormal karyotypes, both structurally and numerically, were chromosomes 5, 7, and 14. A trisomy 5 was found in 2 cases, 1 of which (a) had a reciprocal translocation t(5;8)(p15;q24) as well. The trisomy 5 in patient Groe was present in almost all metaphases obtained from the spleen and from a later blood sample as well. A third patient (W-J) also had a translocation of chromosome 5, but in this case, both the breakpoint and the autosome involved were different.
Chromosome 7 was also found to be involved in five cases, three with clonal and two with nonclonal abnormalities. In one (No), a reciprocal translocation t(2;7)(pl l;q36) was found. The second and third patient (Wen & Wy) had a dicentric chromosome 7 composed of a dic(7; 17)(qll;pl1) For personal use only. on August 16, 2017 . by guest www.bloodjournal.org From 47,XY,+5,t(5;8)(pl5;q24~,add(15)~pl1.2~I201/   46,XY,t~2;7)(pll;q36)l15Y46,XYl41  46,XX[211/45,X,-X,add(4~(p15),de10(q24~111  46,XX,der(18~t(5;18) For personal use only. on August 16, 2017 . by guest www.bloodjournal.org From and a dic(7;22)(qll;pll), respectively. In both of these patients, the abnormal chromosomes were identified as dicentric after CBG-banding. One other patient showed a nonclonal complex translocation between chromosomes 7, 8, and 11. The other nonclonal abnormality was a deletion of 7q32.
Similarly, three cases showed abnormalities of 14q, the breakpoints of which presumably involved the Ig heavychain locus. These abnormalities were manifested either in the form of a reciprocal translocation t( 1 ; 14)(p3 1 ; q32) (patient Ank), a deletion of chromosome 14 at band 24 (patient vB), or a telomere-telomere translocation of chromosome 14 at band q32 (patient Ber). However, this latter abnormality was nonclonal.
All of the structural and numerical abnormalities reported here were confirmed by FISH painting using DNA probe cocktails for whole chromosomes.
Immunophenotypic analysis of metaphase spreads was successful in eight of nine cases. A total number of 105 metaphases (median per patient, 11; range, 7 to 27) was analyzed. No CD3+ metaphases were seen (0/25 metaphases, six cases studied), whereas the large majority of cases reacted with a cocktail of anti-CD19 and CD20 MoAbs (65466 metaphases, eight cases studied) (Fig 1, G and H) . Fourteen metaphases showed inconclusive results mainly because of poor quality of the metaphase figures or to an ambiguous fluorescence pattern. Two-color-fluorescence with anti-rc and anti-X chains also gave inconclusive results, eg, signals that were too weak or double fluorescence in all metaphases tested. Using the same fixation technique, it was also possible to detect TRAP activity in the metaphases (Fig 1F) .
DISCUSSION
In contrast with most previous B-cell culture systems that are generally dependent on the use of chemical B-and Tcell mitogens, the CD40 system uses IL-4 and agonistic anti-CD40 MoAbs cross-linked via a CD32 (FcyII receptor) expressing fibroblast cell line. For normal B cells, the CD40 system has been hypothesized to function as an in vitro germinal center environment." This hypothesis is supported by the fact that germinal center T cells express both IL-4 and the ligand for CD40. Moreover, CD40 expression has been detected on follicular dendritic cells and interdigitating cells.36 The CD40 system has proved to be an excellent tool for inducing proliferation of low-grade B-cell malignancies that, thus far, have been very difficult to study because of their very low proliferating capacity. Here, we show that in addition to CLL,23,24 most HCL cells also respond very well in this CD40 system. We have carefully verified by cytochemical and immunophenotypical analysis of the cultured cells that the proliferation found could conclusively be ascribed to the hairy cells and not to residual T cells.3 Both cell suspensions and metaphase figures were analyzed. In all cases tested, MGG and TRAP stainings of the cultured cells showed hairy cell characteristics. Moreover, in none of the cases was reactivity with anti-CD3 MoAbs found, whereas strong positive reactions with anti-CD19 and anti-B-ly-7 were seen.
Although HCL seems to be a rather homogeneous disease, the tumor cells from different HCL patients did not react uniformly upon anti-CD40 and IL-4 stimulation. In contrast with normal B cells and CLL, cross-linking of anti-CD40 via CD32L cells did not always further enhance the proliferation. Several samples also showed proliferation using anti-CD40 alone with or without additional IL-4, which confirms earlier studies by Ledbetter et all8 who tested two HCL cases with the CD40 MoAb G28-5 before the CD40 system was introduced. We did not study the efficacy of other B-cellspecific MoAbs cross-linked via their Fc receptor. However, Banchereau, who introduced the CD40 system for normal B cells, studied the proliferative capacity of a variety of Bcell-specific MoAbs presented on CD32L cells. Only anti-CD40 MoAbs induced proliferation, whereas MoAbs to CD19, CD21, CD23, CD24, and CD37 did not."
The CD40 system appears very effective in obtaining cytogenetic data. A large series of HCL cases could be analyzed in short-term cultures without the need for B-cell mitogens. We achieved a remarkably high success rate (98%) with sufficient numbers of good-quality metaphases in almost all of the patients examined. In 19% of the cases, clonal abnormalities were found involving different chromosomes. We have taken special care to further evaluate those HCL cases with a normal karyotype, to exclude the possibility that the metaphases originated from T-cell proliferation. By combined immunophenotyping of the metaphase cells, we were able to confirm the B-cell lineage in all cases tested. It is obvious that we cannot entirely exclude the possibility that we cultured some normal B cells as well. However, the cultured cells showed light-chain restriction and reactivity with the HCL-specific MoAb B-ly-7 in the absence of CD3 reactivity. Moreover, we found TRAP-positive metaphases that also supports the HCL lineage. 30 The cytogenetic abnormalities found in the CD40 system were mainly related to the chromosomes 5,7, and 14. Abnormalities with chromosome 5 are extremely rare in B-cell malignancies and have not been described in HCL7-9.",37 until recently when Juliussion et al reported trisomy 5, and/or pericentric inversions and interstitial deletions involving chromosome 5." We confirmed the presence of trisomy 5 further by using FISH on interphase nuclei (data not shown). In a recent study on interphase nuclei of 24 cases with HCL, we did not find numerical abn~rmalities.~' However, chromosome 5 was not assessed at that time.
As far as chromosome 7 is concerned, we found involvement of 7q32 in one case and of 7qll in two others. The presence of t(2;7)(pll;q36) suggests involvement of the K light gene; however, the break in chromosome 22 in patient Wy with a dic(7;22)(qll;pll) cannot be related to the A light gene because this is located on 22q. Interestingly, abnormalities with chromosome 7q have recently been described in five patients from a large series on splenic lymphoma with villous lymphocyte^.'^ In two patients of this series, chromosome 2pl1 was also involved in the translocation together with chromosome 7q. In addition, Dr D. Leroux (personal communication, presented at the Meeting on Mantle Cell Lymphoma, Annecy, February 1994) menFor personal use only. on August 16, 2017 . by guest www.bloodjournal.org From tioned abnormalities of chromosome 7 in 5 cases with an atypical form of mantle cell lymphoma without t ( 11; 14) .
Finally, clonal chromosome 14q involvement in HCL has been described in 5 of a series of 12 HCL patients (12 of 19 eligible patients)," which we also found in two of our cases, whereas two other patients harbored a single abnormality of chromosome 1%.
In conclusion, the CD40 system is one of the first reliable tools to culture hairy cells for cytogenetic analysis. In addition, utilization of this system should also make it possible to obtain more insight into the sensitivity of hairy cell leukemia to various cytokines.
